Synthesis and anticonvulsant activity of 5-chloro-2(3H)-benzoxazolinone-3- acetyl-2-(o/p-substituted benzal) hydrazone derivatives

Arzneimittel-Forschung/Drug Research

Volumn 58, Issue 11, 2008, Pages 537-542

  Gökçe, Mehtap ^a   Geciken, Ahmet Emin ^a   Yildirim, Engin ^b   Tosun, Ali Ulvi ^a  

^a GAZI UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

5 Chloro 2(3H) benzoxazolinones, acetohydrazide, anticonvulsant activity, benzal hydrazines, synthesis; Anticonvulsant drugs

Indexed keywords

5 CHLORO 2(3H) BENZOXAZOLINONE 3 ACETYL 2 (2 METHOXYBENZALDEHYDE)HYDRAZONE; 5 CHLORO 2(3H) BENZOXAZOLINONE 3 ACETYL 2 (2 METHYBENZALDEHYDE)HYDRAZONE; 5 CHLORO 2(3H) BENZOXAZOLINONE 3 ACETYL 2 (4 DIMETHYLAMINOBENZALDEHYDE)HYDRAZONE; 5 CHLORO 2(3H) BENZOXAZOLINONE 3 ACETYL 2 (4 METHYBENZALDEHYDE)HYDRAZONE; 5 CHLORO 2(3H) BENZOXAZOLINONE 3 ACETYL 2 (4 NITROBENZALDEHYDE)HYDRAZONE; HYDRAZONE DERIVATIVE; PHENYTOIN; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MALE; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 57649135212     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296554     Document Type: Article

References (37)

1. Grunwald C, Rundfeldt C, Lankau HJ, Arnold T, Höfgen N, Dost R. Synthesis, pharmacology, and structure-activity relationships of novel imidazolones and pyrrolones as modulators of GABA receptors. J Med Chem. 2003;49(6):1855-1866.
2. Grimm JB, Stables JP, Brown ML. Design, synthesis, and development of novel caprolactam anticonvulsants. Bioor Med Chem. 2003;11:4133-4141.
3. Davies-Jones GB, Anticonvulsants. In: Meyler's Side Effects of Drugs. 11th ed. New York: Elsevier Science Publishers; 1998. p. 120-136.
4. Pandeya SN, Yogeeswari P, Stables JP. Synthesis and anticonvulsant activity of 4-bromophenyl substituted aryl semicarbazones. Eur J Med Chem. 2000;35:879-886.
5. Sridhar SK, Pandeya SN, Stables JP, Ramesh A. Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives. Eur J Pharm Sci. 2002;16:129-132.
6. Joy RM, Edmonds HL. The antagonism of hippocampal and cortical afterdischarge by SC-13504, a new anticonvulsant. Neuropharmacology. 1974;13:145-157.
7. Gürsoy A, Karali N, Büyüktimkin S, Demirayak Ş, Ekiniç A C, Özer H. Some Hydrazono-2-indolinones and N-Mannich Bases as potential Anticonvulsants. Farmaco. 1996;51:437-442.
8. Karali K, Gürsoy A. Synthesis and Anticonvulsant Activity of Some New Thiosemicarbazide and Thiazolidone Derivatives bearing and Isatin Moiety. Farmaco. 1994;49:819-822.
9. Sridhar SK, Ramesh A. Synthesis and pharmacological activities of hydrazones, Schiff and mannich bases of isatin derivatives. Biol Pharm Bull. 2002;24:1149-1152.
10. Sridhar SK, Ramesh A. Synthesis and Pharmacological Activities of Schiff Bases and Hydrazones of Isatin Derivatives. Indian Drugs. 2001;38:174-184.
11. Doǧruer DS, Ünlü S, Şahin MF, Yeşilada E. Antinociceptive and anti-inflammatory activity of some (2-benzoxazolone-3-yl and 2-benzothiazolone-3-yl) acetic acid derivatives. Farmaco. 1998;53:80-84.
12. Erdoǧan H, Ünlü S.,Analgesic activity of some 3-(arylpiperidinomethyl)-2- benzoxazolinone derivatives. Arch Pharm (Weinheim). 1989;322:75-77.
13. Erol DD, Sunal R, Duru S. Synthesis and screening of analgesic and antiinflammatory activity of 6-acyl-3-(4-substituted benzoylmethyl)-2(3H)- benzoxazolones. Arzneimittel-Forschung (Drug Research). 1990;40:478-480.
14. 2. J Med Chem. 1992;35:1296-1299.
15. Önkol T, Ito S, Yildirim E, Erol K, Şahin MF. Synthesis and antinociceptive activity of (2-benzazolon-3-yl)propanamide derivatives. Arch Pharm Med Chem. 2001; 334:17-24.
16. Poupaert J, Carato P, Colacino E, Yous S. 2(3H)-benzoxazolone and bioisosters as "privileged scaffold" in the design of pharmacological probes. Curr Med Chem. 2005;12, 877-885.
17. Kolasa K, Kleinrok Z. Central effect of various new carbamide and succinimide derivatives of benzoxazol-2-one. Acta Pol Pharm. 1981;38:369-377.
18. Kolasa K, Kleinrok Z. Central effect of new acyl- and aminomethyl benzoxazolone-2 Derivatives. Acta Pol. Pharm. 1979;36:383-391.
19. Dalkara S, Çaliş Ü, Sunal R. Synthesis and anticonvulsant activity of some new 2(3H)-benzoxazolone derivatives. J Pharm Belg. 1988;43(5):372-378.
20. 1 receptor ligands. Eur J Pharm. 1997;355:267-273.
21. Uçar H, Van derpoorten K, Cacciaguerra S, Spampinato S, Stables JP, Depovere P, et al. J Med Chem. 1998;41:1138-1145.
22. Onkol T, Şahin MF, Yildirim E, Erol K, Ito S. Synthesis and antinociceptive activity of 5-chloro-2(3H)-benzoxazolon-3-yl)propanamide derivatives. Arch. Pharm Res. 2004;27:1086-1092 (2004).
23. Gulcan HO, Kupeli E, Unlu S, Yesilada E, Sahin MF. 4-(5-chloro-2(3H)- benzoxazolon-3-yl) Butanoic Acid Derivatives: Synthesis, Antinociceptive and Anti-inflammatory Properties. Archiv der Pharm. 2003;336:477-482.
24. Çakir B, Yildirim E, Ercanli T, Erol K, Şahin MF. Synthesis and anticonvulsant activity of some (2/4-substituted)benzaldehyde (2-oxobenzothiazolin-3-yl)acetohydrazones. Farmaco. 54, 842-845 (1999).
25. Çakir B, Daǧ Ö, Yildirim E, Erol K, Şahin MF. Synthesis and anticonvulsant activity of some hydrazones of 2[3(H)- oxobenzoxazolin-3-yl-aceto]hydrazide. J Fac Pharm Gazi. 2001;18(2):99-106.
26. Zylan Z, Ateş N. Age-related changes in regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by pentylenetetrazol. Neurosci Lett. 1989;96:179-184.
27. Czuczwar SJ, Chodkowska AA, Kleinrok Z, Molek U, Jagiellowojtowiez F. Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs. Eur J Pharmacol. 1990;176:75-83.
28. 1H NMR spectroscopic studies of some 6-chloro,2-pyridyl hydrazones. Spectrochim Acta A Mol Biomol Spectrosc. 65, 206-214 (2006).
29. Tóth M, Somsák L, Preparation of 2,6-anhydro-aldose acylhydrazones, semicarbazones and -oximes from 2,6-anhydro-aldononitriles (glycosyl cyanides). Carbohydr Res. 2003;338:1319-1325.
30. Shindikar AV, Khan F, Viswanathan CL. Design, synthesis and in vivo anticonvulsant screening in mice of novel phenylacetamides. Eur J Med Chem. 2006;41:786-792.
31. Yogeeswari P, Thirumurugan R, Kavya R, Samuel JS, Stables JS, Sriram D. 3-Chloro-2-methylphenyl-substituted semi-carbazones: synthesis and anticonvulsant activity. Eur J Med Chem. 2004;39:729-734.
32. Macdonald RL. Antiepileptic drug actions. Epilepsia. 1989;30:19-28.
33. Kaminow L, Schimschock JR, Hammer AE, Vuong A. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. Epilepsy Behavior. 2003;4:659-666.
34. Goodwin M, Wade D, Luke B, Davies P, A survey of a novel epilepsy clinic. Seizure, 2002;11:519-522.
35. Archana VK, Kumar A.,Synthesis of newer thiadiazolyl and thiazolidinonyl quinazolin-4(3H)-ones as potential anticonvulsant agents. Eur J Med Chem. 2002;37:873-882.
36. Bin HA, Crider M, Stables JP. Synthesis and structure - activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acid and related pharmacophores. Eur J Med Chem. 2001;36, 265-286.
37. Bosch J, Roca T, Domènech J, Suriol M. Synthesis of water-soluble phenytoin prodrugs. Bioorg Med Chem Lett.1999;9:1859-1862.